The Equitile Resilience Fund aims to deliver capital growth by investing in large, growing companies in the developed world. It is managed according to our core investment principles and uses the Equitile Fair Fee Model.
Latest Overview - November 2017 (print version)
November has been another month of strong investment returns for your fund. This month some of the largest positive contributions to returns came from your investments in the world-leading medical technology companies Align Technology, Intuitive Surgical and Teleflex. That said, another medical technology firm, the hearing aid manufacturer Sonova, was your largest negative contributor in the month.
Align Technology, is especially noteworthy as its Invisalign orthodontic treatment is enjoying rapid growth globally. In November the company announced that its five millionth patient had begun treatment.
As this will be our last monthly update before the holiday season, the team here at Equitile would like to wish all our investors a very Merry Christmas.